Document is current
Any future updates will be listed below
-
Authors
Nalavade, Rohit https://orcid.org/0000-0002-9040-8485
Mirza, Aashiq H https://orcid.org/0000-0002-9655-5267
Jaffrey, Samie R https://orcid.org/0000-0003-3615-6958
-
Funding
Funding for this research was provided by:
HHS | National Institutes of Health (R35NS111631)
HHS | National Institutes of Health (RM1HG011563)
HHS | National Institutes of Health (S10 OD030335)
HHS | National Institutes of Health (R01CA186702)
HHS | NIH | National Cancer Institute (CA062948)
- License Information
-
More Information
Article History
Received: 25 November 2025
Revised: 21 May 2026
Accepted: 8 June 2026
First Online: 23 June 2026
Disclosure and competing interests statement
: SRJ is the co-founder of Lucerna Technologies and holds equity in the company, which has licensed technology related to Spinach, Broccoli, and other RNA-fluorophore complexes. SRJ is also a founder of Chimerna Therapeutics and holds equity in the company. The remaining authors declare no competing interests.
